๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

9 recruiting trials

for VEXAS Syndrome

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) NCT06782373Phase 239 sites๐Ÿ“ Scottsdale๐Ÿ“ Boston๐Ÿ“ Rochester Swedish Orphan Biovitrum ยท Tests: Pacritinib, Placebo A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome NCT05027945Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Allogeneic HSCT, Busulfan test dose, Mycophenolate mofetil (MMF), Tacrolimus, Busulfan Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome NCT06538181Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Pacritinib HRQoL and Financial Toxicity in Patients With VEXAS Syndrome NCT06657846n/a17 sites๐Ÿ“ Ancona๐Ÿ“ Bergamo๐Ÿ“ Bologna Gruppo Italiano Malattie EMatologiche dell'Adulto Momelotinib in VEXAS Syndrome NCT07098936Phase 211 sites๐Ÿ“ Angers๐Ÿ“ Clermont-Ferrand๐Ÿ“ Lille Groupe Francophone des Myelodysplasies ยท Tests: Momelotinib treatment AutoInflammatory Disease Alliance Registry (AIDA) NCT05200715n/a112 sites๐Ÿ“ Algiers๐Ÿ“ Boumerdas๐Ÿ“ Adelaide University of Siena ยท Tests: No intervention is foreseen by the protocol. Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection NCT06377462n/a17 sites๐Ÿ“ Aachen๐Ÿ“ Chemnitz๐Ÿ“ Dresden Technische Universitรคt Dresden A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period NCT07748624Phase 24 sites๐Ÿ“ Yokohama๐Ÿ“ Suita๐Ÿ“ Hachiลji Novartis Pharmaceuticals ยท Tests: Arumakimig, Placebo, Oral glucocorticoids Autoimmune and Autoinflammatory Genetics Study NCT06004349n/a2 sites๐Ÿ“ New York๐Ÿ“ New York NYU Langone Health
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy